BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10956322)

  • 1. AT(1) receptor antagonists-beyond blood pressure control: possible place in heart failure treatment.
    McMurray J
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i42-5: discussion i50. PubMed ID: 10956322
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction.
    McMurray JJ
    Heart; 2001 Jul; 86(1):97-103. PubMed ID: 11410575
    [No Abstract]   [Full Text] [Related]  

  • 3. [Angiotensin I receptor blockers for heart failure].
    Fruhwald FM; Kickenweiz E; Zweiker R; Klein W
    Wien Med Wochenschr; 2001; 151(7-8):157-9. PubMed ID: 11450163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibition and AT(1) receptor blockers: efficacy and duration in hypertension.
    Meredith PA
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i39-41; discussion i50. PubMed ID: 10956321
    [No Abstract]   [Full Text] [Related]  

  • 5. [Angiotensin-II-receptor antagonists for cardiac insufficiency].
    Kromer EP
    Internist (Berl); 2000 Sep; 41(9):917-24. PubMed ID: 11006881
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapies following heart failure and myocardial infarction(discussion)].
    Shimizu T; Komuro I; Hirayama H; Hiramitsu S; Shimizu K; Yoshida O
    Nihon Rinsho; 2002 Jun; 60(6):1235-50. PubMed ID: 12143782
    [No Abstract]   [Full Text] [Related]  

  • 8. The CHARM programme raises the profile of candesartan cilexetil in the treatment of chronic health failure.
    Cardiovasc J S Afr; 2004; 15(1):42-3. PubMed ID: 15095753
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiotensin receptor blockers in chronic heart failure].
    Umemoto S; Kawahara S; Hashimoto R; Matsuzaki M
    Nihon Rinsho; 2003 Sep; 61(9):1683-9. PubMed ID: 14515740
    [No Abstract]   [Full Text] [Related]  

  • 10. [Organ protection by angiotensin II receptor blockers].
    Kumagai H; Onami T; Takimoto C; Iigaya K; Saruta T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():569-73. PubMed ID: 15171437
    [No Abstract]   [Full Text] [Related]  

  • 11. [Review of randomized trials of angiotensin receptor blockers in the treatment of patients with congestive heart failure].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2001 Oct; 59(10):2051-61. PubMed ID: 11676153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of candesartan, enalapril and their combination in congestive heart failure].
    Rapezzi C
    Ital Heart J Suppl; 2000 Mar; 1(3):429-30. PubMed ID: 10815278
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conclusions from CHARM interview with Prof. Veselin Mitrovich, Bad Nauheim. Strong evidence: more help for weak hearts].
    Mitrovic V
    MMW Fortschr Med; 2005 Mar; 147(13):48-9. PubMed ID: 15832762
    [No Abstract]   [Full Text] [Related]  

  • 14. Implications of recent clinical trials for heart failure performance measures.
    Executive Council Of The Heart Failure Society Of America
    J Card Fail; 2004 Feb; 10(1):4-5. PubMed ID: 14966767
    [No Abstract]   [Full Text] [Related]  

  • 15. [AT1 blockers against heart failure. The charm of polypharmacy].
    MMW Fortschr Med; 2003 Sep; 145(38):6. PubMed ID: 14603670
    [No Abstract]   [Full Text] [Related]  

  • 16. RAS blockade: new possibilities in the treatment of complications of diabetes.
    Ruilope L
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i32-4:discussion i50. PubMed ID: 10956319
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploring new treatment strategies in heart failure.
    Swedberg K
    Blood Press Suppl; 2000; 1():44-8. PubMed ID: 11059637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ACE inhibitors or AT1 receptor antagonists?].
    Riegger GA
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetic nephropathy: evidence for renoprotection and practice.
    Mogensen CE
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i26-8:discussion i50. PubMed ID: 10956317
    [No Abstract]   [Full Text] [Related]  

  • 20. [CHARM study--new strategy for the treatment of heart failure].
    Hasegawa H; Komuro I
    Nihon Rinsho; 2004 May; 62(5):995-1002. PubMed ID: 15148833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.